PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BEAM vs. VOO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between BEAM and VOO is 0.42, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.4

Performance

BEAM vs. VOO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Beam Therapeutics Inc. (BEAM) and Vanguard S&P 500 ETF (VOO). The values are adjusted to include any dividend payments, if applicable.

-30.00%-20.00%-10.00%0.00%10.00%AugustSeptemberOctoberNovemberDecember2025
-22.69%
8.64%
BEAM
VOO

Key characteristics

Sharpe Ratio

BEAM:

-0.04

VOO:

2.21

Sortino Ratio

BEAM:

0.52

VOO:

2.92

Omega Ratio

BEAM:

1.06

VOO:

1.41

Calmar Ratio

BEAM:

-0.03

VOO:

3.34

Martin Ratio

BEAM:

-0.07

VOO:

14.07

Ulcer Index

BEAM:

40.04%

VOO:

2.01%

Daily Std Dev

BEAM:

72.94%

VOO:

12.80%

Max Drawdown

BEAM:

-86.76%

VOO:

-33.99%

Current Drawdown

BEAM:

-82.46%

VOO:

-1.36%

Returns By Period

In the year-to-date period, BEAM achieves a -5.48% return, which is significantly lower than VOO's 1.98% return.


BEAM

YTD

-5.48%

1M

-19.20%

6M

-13.35%

1Y

-1.06%

5Y*

N/A

10Y*

N/A

VOO

YTD

1.98%

1M

1.13%

6M

8.46%

1Y

25.58%

5Y*

14.35%

10Y*

13.37%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BEAM vs. VOO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BEAM
The Risk-Adjusted Performance Rank of BEAM is 4444
Overall Rank
The Sharpe Ratio Rank of BEAM is 4343
Sharpe Ratio Rank
The Sortino Ratio Rank of BEAM is 4646
Sortino Ratio Rank
The Omega Ratio Rank of BEAM is 4343
Omega Ratio Rank
The Calmar Ratio Rank of BEAM is 4343
Calmar Ratio Rank
The Martin Ratio Rank of BEAM is 4444
Martin Ratio Rank

VOO
The Risk-Adjusted Performance Rank of VOO is 8383
Overall Rank
The Sharpe Ratio Rank of VOO is 8484
Sharpe Ratio Rank
The Sortino Ratio Rank of VOO is 8181
Sortino Ratio Rank
The Omega Ratio Rank of VOO is 8383
Omega Ratio Rank
The Calmar Ratio Rank of VOO is 8383
Calmar Ratio Rank
The Martin Ratio Rank of VOO is 8585
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BEAM vs. VOO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Beam Therapeutics Inc. (BEAM) and Vanguard S&P 500 ETF (VOO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BEAM, currently valued at -0.04, compared to the broader market-2.000.002.004.00-0.042.21
The chart of Sortino ratio for BEAM, currently valued at 0.52, compared to the broader market-4.00-2.000.002.004.006.000.522.92
The chart of Omega ratio for BEAM, currently valued at 1.06, compared to the broader market0.501.001.502.001.061.41
The chart of Calmar ratio for BEAM, currently valued at -0.03, compared to the broader market0.002.004.006.00-0.033.34
The chart of Martin ratio for BEAM, currently valued at -0.07, compared to the broader market-10.000.0010.0020.0030.00-0.0714.07
BEAM
VOO

The current BEAM Sharpe Ratio is -0.04, which is lower than the VOO Sharpe Ratio of 2.21. The chart below compares the historical Sharpe Ratios of BEAM and VOO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00AugustSeptemberOctoberNovemberDecember2025
-0.04
2.21
BEAM
VOO

Dividends

BEAM vs. VOO - Dividend Comparison

BEAM has not paid dividends to shareholders, while VOO's dividend yield for the trailing twelve months is around 1.22%.


TTM20242023202220212020201920182017201620152014
BEAM
Beam Therapeutics Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VOO
Vanguard S&P 500 ETF
1.22%1.24%1.46%1.69%1.25%1.54%1.88%2.06%1.78%2.02%2.10%1.85%

Drawdowns

BEAM vs. VOO - Drawdown Comparison

The maximum BEAM drawdown since its inception was -86.76%, which is greater than VOO's maximum drawdown of -33.99%. Use the drawdown chart below to compare losses from any high point for BEAM and VOO. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-82.46%
-1.36%
BEAM
VOO

Volatility

BEAM vs. VOO - Volatility Comparison

Beam Therapeutics Inc. (BEAM) has a higher volatility of 18.32% compared to Vanguard S&P 500 ETF (VOO) at 5.05%. This indicates that BEAM's price experiences larger fluctuations and is considered to be riskier than VOO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%AugustSeptemberOctoberNovemberDecember2025
18.32%
5.05%
BEAM
VOO
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab